Hemosiderin is a marker for complex disease in patients undergoing surgery for endometriosis

G.A. Hernandez-Vizcarrondo, Zaraq Khan, Kristin C. Mara, Adela G. Cope, Tatnai L. Burnett
In: American Journal of Obstetrics and Gynecology · 2022 · vol. 226(3) , pp. S1320–S1321 · doi:10.1016/j.ajog.2021.12.088 · W4213379716
article OA: bronze CC0
🔓 Open OA copy View on OpenAlex View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-09 ⓘ

This study identifies hemosiderin accumulation as a significant marker for complex disease in patients undergoing surgery for endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK